comparemela.com

Latest Breaking News On - Solid tumor - Page 4 : comparemela.com

Myriad Genetics Completes Acquisition of Precise Tumor,

SALT LAKE CITY, Feb. 01, 2024 (GLOBE NEWSWIRE) Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today.

Utah
United-states
Matt-scalo
Glenn-farrell
Intermountain-health
Nasdaq
Exchange-commission
Genetics-inc
Intermountain-precision-genomics
Tumor-test
Precise-liquid-test
Precise-tumor-test

Myriad Genetics' Strategic Growth Fuels Bullish Outlook (NASDAQ:MYGN)

Myriad Genetics' Strategic Growth Fuels Bullish Outlook (NASDAQ:MYGN)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Japan
Nasdaq
Myriad-genetics
Intermountain-precision-genomics
Solid-tumor
Precise-tumor-test
Intermountain-precision-genomic
Precise-liquid
Precise-treatment-registry
Minimal-residual-disease
Intermountain-precision

Anti-Cancer Monoclonal Antibodies Market to Reach $95.99

Intermountain ends precision medicine program

Intermountain ends precision medicine program
beckershospitalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from beckershospitalreview.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Precision-genomics-laboratory-feb
American-cancer-society
Intermountain-health
Precision-genomics-laboratory
Intermountain-precision-genomics
Solid-tumor
Liquid-biopsy
Myriad-genetics
Salt-lake-city-based

Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

19.01.2024 - SALT LAKE CITY, Jan. 18, 2024 (GLOBE NEWSWIRE) - Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has entered into a definitive agreement to acquire select assets from Intermountain . Seite 1

Paulj-diaz
Intermountain-health-system
Intermountain-healthcare
Precise-tumor-test
Solid-tumor
Precise-liquid
Myriad-genetics-chart
Yriad-genetics-kurs
Yriad-genetics-aktie

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.